- Home
- HALO vs MASI Comparison
HALO vs MASI Comparison
Compare HALO & MASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HALO | MASI |
|---|---|---|
| Founded | 1998 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8B | 9.2B |
| IPO Year | 2001 | 2000 |
Fundamental Metrics
Financial Performance| Metric | HALO | MASI |
|---|---|---|
| Price | $65.90 | $178.51 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 5 |
| Target Price | $78.64 | ★ $184.00 |
| AVG Volume (30 Days) | ★ 1.2M | 623.8K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 51.05 |
| EPS | ★ 2.56 | N/A |
| Revenue | $151,862,000.00 | ★ $1,239,153,000.00 |
| Revenue This Year | $28.24 | $8.59 |
| Revenue Next Year | $12.56 | $7.66 |
| P/E Ratio | $25.24 | ★ N/A |
| Revenue Growth | N/A | ★ 8.34 |
| 52 Week Low | $47.50 | $125.94 |
| 52 Week High | $82.22 | $179.00 |
Technical Indicators
Market Signals| Indicator | HALO | MASI |
|---|---|---|
| Relative Strength Index (RSI) | 50.72 | 64.47 |
| Support Level | $63.85 | $176.68 |
| Resistance Level | $68.00 | $178.87 |
| Average True Range (ATR) | 2.04 | 0.26 |
| MACD | -0.16 | -0.35 |
| Stochastic Oscillator | 44.27 | 57.98 |
Price Performance
Historical ComparisonAbout HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
About MASI Masimo Corporation
Masimo Corp is a medical technology company. The company oepates in single segment namely Healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. The company sells its products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, and others.